Armata Pharmaceuticals (ARMP) Profit After Tax Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 65.80% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 17.05% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 59.59% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -10.08% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -129.68% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1,228.66% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -1,666.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,666.13% |
| Dec 31, 2025 | -4,880.69% |
| Sep 30, 2025 | -386.68% |
| Jun 30, 2025 | -281.34% |
| Mar 31, 2025 | 73.90% |
| Dec 31, 2024 | 113.10% |
| Sep 30, 2024 | 82.41% |
| Jun 30, 2024 | 353.34% |
| Mar 31, 2024 | -72.68% |
| Dec 31, 2023 | -92.43% |
| Sep 30, 2023 | -261.75% |
| Jun 30, 2023 | 61.51% |
| Mar 31, 2023 | -65.15% |
| Dec 31, 2022 | -70.56% |
| Sep 30, 2022 | -58.96% |
| Jun 30, 2022 | -48.77% |
| Mar 31, 2022 | -59.67% |
| Dec 31, 2021 | 8.71% |
| Sep 30, 2021 | 6.07% |
| Jun 30, 2021 | -31.51% |
| Mar 31, 2021 | -8.21% |
| Dec 31, 2020 | -269.80% |
| Sep 30, 2020 | 17.05% |
| Jun 30, 2020 | -12.17% |
| Mar 31, 2020 | -35.81% |
| Dec 31, 2019 | 454.31% |
| Sep 30, 2019 | -150.99% |
| Jun 30, 2019 | -32.59% |
| Mar 31, 2019 | -19.30% |
| Dec 31, 2018 | 53.19% |
| Sep 30, 2018 | -255.71% |
| Jun 30, 2018 | 50.98% |
| Mar 31, 2018 | 3.45% |
| Dec 31, 2017 | 75.24% |
| Sep 30, 2017 | 67.20% |
| Jun 30, 2017 | -67.77% |
| Mar 31, 2017 | -4.31% |
| Dec 31, 2016 | -325.82% |
| Sep 30, 2016 | -143.67% |
| Jun 30, 2016 | -135.76% |